UK markets closed

Day One Biopharmaceuticals, Inc. (DAWN)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
16.17+0.14 (+0.87%)
At close: 04:00PM EDT
16.17 0.00 (0.00%)
After hours: 04:20PM EDT
Show:
Income statement
Balance sheet
Annual

Cash flow

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Cash flows from operating activities
Net income
-208,936
-188,917
-142,181
-70,645
-40,507
Depreciation & amortisation
410
383
531
199
155
Stock-based compensation
42,538
39,341
27,242
13,321
526
Change in working capital
3,162
9,418
6,564
2,695
-357
Accounts payable
141
2,316
-1,484
1,542
132
Other working capital
-173,795
-150,077
-109,900
-56,539
-13,581
Other non-cash items
-
3,000
-
8,000
30
Net cash provided by operating activities
-170,597
-146,853
-109,874
-48,539
-13,489
Cash flows from investing activities
Investments in property, plant and equipment
-
-3,224
-26
-8,000
-92
Purchases of investments
-330,986
-443,838
-394,206
0
0
Sales/maturities of investments
563,043
575,440
139,158
0
0
Net cash used for investing activities
228,859
128,378
-255,074
-8,000
-92
Cash flows from financing activities
Common stock issued
-
161,409
161,610
167,045
0
Net cash used provided by (used for) financing activities
162,861
163,997
165,901
297,120
29,977
Net change in cash
221,123
145,522
-199,047
240,581
16,396
Cash at beginning of period
49,268
85,262
284,309
43,728
27,332
Cash at end of period
270,391
230,784
85,262
284,309
43,728
Free cash flow
Operating cash flow
-170,597
-146,853
-109,874
-48,539
-13,489
Capital expenditure
-
-3,224
-26
-8,000
-92
Free cash flow
-173,795
-150,077
-109,900
-56,539
-13,581